Skip to content
SMA Foundation
SMA Patient Resources | Donate Now
  • About Us
  • About SMA
  • Our Research
  • Drugs in Development
  • Drugs Discovery Assets

Roche to begin Part 2 of the SUNFISH Trial

September 25, 2017

To read the full press release, please click here: SUNFISH

← Scholar Rock to Develop SRK-015 to Improve Muscle Function in Patients with Spinal Muscular AtrophyAveXis Announces Plan to Initiate Pivotal Trial of AVXS-101 in SMA Type 1 Using Product from New GMP Commercial Process →
© 2023 Spinal Muscular Atrophy Foundation. All Rights Reserved. | Contact Us | Terms of Use
Scroll To Top